Jornal de Demência

Abstrato

Endeavouring the latest advancements in Neuroscience and Neurological Disorders

Andrea S. Bonzini

Neurological disorders have exaggerated lots of people universally ranging from epilepsy to Alzheimer disease, from stroke to headache. As appraised by WHO around 6.8 million people die each year due to these neurological disorders. The economic cost of neurological diseases was estimated at about 139 billion euros in 2004 in Europe.
The massive increase within the global marketplace for the neurological devices shows us the growing example of cerebral stroke, acute and chronic disorders like Epilepsy, Alzheimer’s, Parkinson’s, Huntington’s, Movement Disorders, Ataxia, Cerebrovascular disease, Multiple Sclerosis, etc…
It is estimated that 50 million U.S. people are affected by such neurological disorders which eventually lead to high expenditure treatment methods. The Transparency Market Research finds that it would reach a value of USD 13.6 billion in 2021 by the inspiring step which was available with a current report for neuroscience marketing device.